One-year experience of bedside percutaneous VA-ECMO decannulation in a high-ECMO-volume center in Hong Kong

Background: When veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support can be terminated, open repair of arteriotomy wounds in operating theaters is the standard of practice. Comparable outcomes by percutaneous decannulation using different closure devices have been reported. However,...

Full description

Saved in:
Bibliographic Details
Published in:Perfusion 2021-11, Vol.36 (8), p.803-807
Main Authors: Au, Shek-Yin, Chan, Kwong-Shun, Fong, Ka-Man, Leung, Pui-Wah Rowlina, Ng, Wing-Yiu George, So, Sheung-On, Leung, Kit-Hung Anne
Format: Article
Language:English
Subjects:
Complications
Extracorporeal Membrane Oxygenation
Hemorrhage
Hong Kong
Humans
Male
Operating theaters
Oxygenation
Pseudoaneurysm
Repair
Retrospective Studies
Wound healing
Wound infection
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: When veno-arterial extracorporeal membrane oxygenation (VA-ECMO) support can be terminated, open repair of arteriotomy wounds in operating theaters is the standard of practice. Comparable outcomes by percutaneous decannulation using different closure devices have been reported. However, transport of the critically- ill, man-power and timeslots of operating theaters could be saved if decannulation was performed at bedside. Method: Bedside percutaneous arteriotomy wound closure became our default method of decannulation since November 2018. We reviewed our 1-year data to evaluate if such practice could be safely adopted in a local high-ECMO-volume center. Results: Between November 2018 and October 2019, 25 patients had their VA-ECMO terminated at the bedside. Twenty-one patients (84%) had successful decannulation. For those who failed, emergency open repair resulted in no additional complications. Two ProGlide devices were used in 15 (71.4%) patients and three were used in 6 (28.6%) patients. The procedure time was 27 (15–45) min. The median blood loss was 300 mL (250–400). Minor complications were found in 4 (19.1%) patients, including two arterial clot formation, one pseudoaneurysm and one wound infection. There were no other major complications. Conclusion: Our 1-year experience showed that percutaneous bedside VA-ECMO decannulation was feasible to commence in a local large-ECMO-volume center.
ISSN:0267-6591
1477-111X
DOI:10.1177/0267659120971998